Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
Clinical trial NCT00274989 · COMPLETED
Trial details
- NCT number
- NCT00274989
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-03-01
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.